Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of Schizophrenia
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of Schizophrenia
A Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of Schizophrenia
Am J Psychiatry. 2002 Apr;159(4):554-60.
Am J Psychiatry. 2002 Apr;159(4):554-60.
OBJECTIVE:
Maintenance medication is critical in the prevention of psychotic relapse and rehospitalization among patients with schizophrenia. Given potential adverse effects, identification of the minimum effective dose is clinically important.
METHOD:
A multicenter, double-blind study was conducted to determine rates of symptomatic exacerbation and adverse effects in 105 outpatients with schizophrenia randomly assigned to four different fixed doses of haloperidol decanoate and treated for 1 year or until relapse. The doses used were 25, 50, 100, and 200 mg given intramuscularly once per month.
RESULTS:
- Rates of symptomatic exacerbation were 15% in the 200-mg group, 23% with 100 mg, 25% with 50 mg, and 60% with 25 mg.
- No significant differences in outcome were found between the groups treated with 200, 100, and 50 mg.
- Among the patients who completed the trial with no symptomatic exacerbation, there were no differences between dose groups on measures of psychopathology at the final rating point.
CONCLUSIONS:
- The results of this study suggest that the 200-mg/month dose of haloperidol decanoate is associated with the lowest rate of symptomatic exacerbation (15%) with minimal increased risk of adverse effects or subjective discomfort in comparison to 100 or 50 mg.
- At the same time, the rates of worsening with 100 mg (23%) and 50 mg (25%) were not significantly greater than that seen with 200 mg.
- These results provide some guidance as to effective dose ranges of haloperidol decanoate.
Similar topics
» Haloperidol & Fluphenazine Decanoate & Risperidone Consta- Dose Calculation
» minocycline treatment for schizophrenia?
» Clonazepam in treatment of Panic Disorder with or without agoraphobia: Dose-Response Study of Efficacy, Safety, and Discontinuance
» Schizophrenia Treatment: During Pregnancy & Postpartum- Update
» Gingko Biloba for treatment of Tardive Dyskinesia in Schizophrenia
» minocycline treatment for schizophrenia?
» Clonazepam in treatment of Panic Disorder with or without agoraphobia: Dose-Response Study of Efficacy, Safety, and Discontinuance
» Schizophrenia Treatment: During Pregnancy & Postpartum- Update
» Gingko Biloba for treatment of Tardive Dyskinesia in Schizophrenia
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin